H. H. Schrenk
- Molecular Biology
- Biomaterials top 10%
- Radiology, Nuclear Medicine and Imaging
- Oncology
- Biomedical Engineering
- Topics
- Radiopharmaceutical Chemistry and Applications (6 papers)Cancer, Hypoxia, and Metabolism (4 papers)MRI in cancer diagnosis (2 papers)
- Partner nations
- GermanyUnited StatesBulgaria
In The Last Decade
H. H. Schrenk
22 papers receiving 413 citations
Peers
Comparison fields: 5 of 79
- Molecular Biology 147
- Biomaterials 112
- Radiology, Nuclear Medicine and Imaging 103
- Oncology 93
- Biomedical Engineering 54
Countries citing papers authored by H. H. Schrenk
This map shows the geographic impact of H. H. Schrenk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. H. Schrenk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. H. Schrenk more than expected).
Fields of papers citing papers by H. H. Schrenk
This network shows the impact of papers produced by H. H. Schrenk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. H. Schrenk. The network helps show where H. H. Schrenk may publish in the future.
Co-authorship network of co-authors of H. H. Schrenk
This figure shows the co-authorship network connecting the top 25 collaborators of H. H. Schrenk. A scholar is included among the top collaborators of H. H. Schrenk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. H. Schrenk. H. H. Schrenk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 22 | |
| 2 | 4 | |
| 3 | 3 | |
| 4 | Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society. | 81 |
| 5 | 4 | |
| 6 | 59 | |
| 7 | 2 | |
| 8 | 5 | |
| 9 | 37 | |
| 10 | 55 | |
| 11 | 77 | |
| 12 | 6 | |
| 13 | 5 | |
| 14 | 1 | |
| 15 | 19 | |
| 16 | The pulmonary effects of synthetic silicates derived from diatomaceous earth. | 1 |
| 17 | The effects of a synthetic ceramic fiber dust upon the lung of rats. | 8 |
| 18 | 8 | |
| 19 | 2 | |
| 20 | 1 |
About H. H. Schrenk
H. H. Schrenk is a scholar working on Chemical Health and Safety, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 24 papers that have together received 440 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and MRI in cancer diagnosis (2 papers). The work is most often cited by research in Biomaterials (112 citations), Chemical Health and Safety (4 citations) and Radiology, Nuclear Medicine and Imaging (103 citations). H. H. Schrenk has collaborated with scholars based in Germany, United States and Bulgaria. Frequent co-authors include E. Friedrich, W. Maier‐Borst, H. Sinn, H. A. Dresel, D P Via, G. Stehle, A. Wunder, D. L. Heene, Peter Peschke and G. Hartung. Their work appears in journals such as Analytical Biochemistry, European Journal of Cancer and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.